IL-5 pathway inhibition in the treatment of asthma and Churg-Strauss syndrome

J Allergy Clin Immunol. 2010 Jun;125(6):1245-6. doi: 10.1016/j.jaci.2010.04.022.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Asthma / immunology
  • Asthma / physiopathology
  • Asthma / therapy*
  • Churg-Strauss Syndrome / immunology
  • Churg-Strauss Syndrome / physiopathology
  • Churg-Strauss Syndrome / therapy*
  • Eosinophilia / prevention & control
  • Humans
  • Immunotherapy*
  • Interleukin-5 / antagonists & inhibitors*
  • Nasal Polyps / prevention & control
  • Receptors, Interleukin-5 / immunology
  • Secondary Prevention
  • Signal Transduction / drug effects
  • Signal Transduction / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • Receptors, Interleukin-5
  • reslizumab
  • mepolizumab